Gα 13 activators represent a class of chemicals that intricately modulate the activity of Gα 13, a crucial member of the G protein family involved in transducing signals from cell surface receptors to downstream effectors. The activation of Gα 13 is intricately linked to the regulation of various cellular processes, particularly those associated with cytoskeletal dynamics, cell migration, and survival. Understanding the pharmacological modulation of Gα 13 activation sheds light on the intricate signaling pathways that govern these fundamental cellular responses. One subset of Gα 13 activators includes lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P), which directly bind to their respective receptors, leading to Gα 13 activation and subsequent signaling cascades. These activators play a pivotal role in regulating cell motility and adhesion by influencing the Rho GTPase pathway. Additionally, chemicals such as Y-27632 and C3 exoenzyme indirectly impact Gα 13 by modulating downstream effectors like Rho-associated protein kinase (ROCK) and Rho GTPases, highlighting the intricate interplay within the Gα 13 signaling network.
Other Gα 13 activators offer a unique perspective by indirectly influencing Gα 13 activation. By inhibiting specific receptors, these compounds attenuate Gα 13-mediated signaling events, providing valuable insights into the regulatory mechanisms governing Gα 13-associated pathways. Furthermore, inhibitors targeting downstream effectors, such as Rac1 and RhoA, contribute to our understanding of how Gα 13 orchestrates diverse cellular responses, from cytoskeletal rearrangement to migration. In conclusion, Gα 13 activators represent a diverse array of chemicals that directly or indirectly impact Gα 13 signaling, unraveling the complexities of this crucial G protein in cellular regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $96.00 $334.00 | 50 | |
LPA activates Gα 13 by binding to LPA receptors, leading to the activation of downstream signaling cascades such as the Rho GTPase pathway. This activation promotes cellular responses, including cytoskeletal rearrangement and migration, linking Gα 13 to the regulation of cell motility and adhesion. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
S1P activates Gα 13 by binding to S1P receptors, initiating signaling pathways involved in cellular processes such as migration and survival. Gα 13 mediates the effects of S1P by regulating Rho GTPase activity, highlighting its role in modulating cytoskeletal dynamics and cell behavior. | ||||||
EHop-016 | 1380432-32-5 | sc-497382 | 5 mg | $78.00 | ||
EHop-016 inhibits RhoA, a key player in the Rho GTPase signaling pathway downstream of Gα 13. By targeting RhoA, this compound indirectly modulates Gα 13-mediated cellular responses, including cytoskeletal rearrangement and migration. | ||||||
SU 6668 | 252916-29-3 | sc-204309 sc-204309A | 10 mg 50 mg | $127.00 $712.00 | 2 | |
This antagonist inhibits the LPA2 receptor, leading to decreased activation of Gα 13 and downstream signaling. By interfering with LPA2 receptor function, this compound can indirectly influence cellular responses mediated by Gα 13, including cytoskeletal rearrangement and migration. This antagonist offers a potential approach for modulating Gα 13-associated pathways and exploring its implications in various biological processes. | ||||||